Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study

1. Philip, P.A.
2. Lacy, J.
3. Portales, F.
4. Sobrero, A.
5. Pazo-Cid, R.
6. Manzano Mozo, J.L.
7. Kim, E.J.
8. Dowden, S.
9. Zakari, A.
10. Borg, C.
11. Terrebonne, E.
12. Rivera, F.
13. Sastre, J.
14. Bathini, V.
15. López-Trabada, D.
16. Asselah, J.
17. Saif, M.W.
18. Shiansong Li, J.
19. Ong, T.J.
20. Nydam, T.
21. Hammel, P.